A Mechanistic Study of MAR001 in Adults With Elevated Triglycerides and Remnant Cholesterol

Research Study of a New Medicine (NNC9204-1706) in People With Overweight or Obesity

NCT03661879 ·Status: COMPLETED ·Phase: PHASE1

A Phase 1, First Time in Humans Study of NST-1024

NCT04630366 ·Status: COMPLETED ·Phase: PHASE1

Trial of the Combination of Alpha-Lipoic Acid and Mirabegron in Women and in Men With Obesity

NCT05713799 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

A Study of the Safety of R256918 in Obese Patients

NCT01041677 ·Status: COMPLETED ·Phase: PHASE2

Evaluation of Omarigliptin (MK-3102) in Obese Participants and in Participants With Type 2 Diabetes (MK-3102-004)

NCT01088711 ·Status: COMPLETED ·Phase: PHASE1

A Study of TG103 Injection in Overweight or Obesity

NCT05299697 ·Status: UNKNOWN ·Phase: PHASE2

Effects of NT-0796 in Obese Participants at Risk of Cardiovascular Disease

NCT06129409 ·Status: COMPLETED ·Phase: PHASE1

Phase 2a Study of Safety, Tolerability, and Efficacy of TLC-2716 in Subjects With Hypertriglyceridemia and NAFLD

NCT06564584 ·Status: RECRUITING ·Phase: PHASE2

A 1-Year Study of an Investigational Drug in Obese Patients (0557-012)(COMPLETED)

NCT00092872 ·Status: COMPLETED ·Phase: PHASE3

Effect of Liraglutide for Weight Management in Pubertal Adolescent Subjects With Obesity

NCT02918279 ·Status: COMPLETED ·Phase: PHASE3

Obese Patients With Untreated Dyslipidemias

NCT00029835 ·Status: COMPLETED ·Phase: PHASE3

First in Human Study in Subjects With Obesity, But Otherwise Healthy

NCT06252220 ·Status: RECRUITING ·Phase: PHASE1

First Human Dose Trial Investigating Safety, Tolerability and Pharmacokinetics of NNC0194-0499 in Male Subjects With Overweight or Obesity

NCT03015207 ·Status: COMPLETED ·Phase: PHASE1

Multiple Dose Study Of PF-05231023 In Obese Adult Subjects

NCT01923389 ·Status: TERMINATED ·Phase: PHASE1

Safety and Efficacy of MK0736 & MK0916 in Patients With Hypertension (High Blood Pressure)(0736-003)(COMPLETED)

NCT00274716 ·Status: COMPLETED ·Phase: PHASE2

To Study Different Levels of MK0493 for Safety, Efficacy, and Tolerability in Obese Patients (0493-017)(COMPLETED)

NCT00482196 ·Status: COMPLETED ·Phase: PHASE2

A Study to Determine the Effects of MK0557 in Obese Subjects (0557-006)(COMPLETED)

NCT00533598 ·Status: COMPLETED ·Phase: PHASE2

A Trial Investigating Safety, Tolerability, PK and PD for Multiple Doses of NNC9204-0530 in Male and Female Subjects Being Overweight or With Obesity

NCT02835235 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Efficacy and Safety of PF-06882961 in Adults With Obesity

NCT04707313 ·Status: COMPLETED ·Phase: PHASE2

A Double-blind Randomized Placebo-controlled Study Comparing Epanova and Fenofibrate on Liver Fat in Overweight Subjects.

NCT02354976 ·Status: COMPLETED ·Phase: PHASE2

Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BGM0504 Tablets in Non-diabetic Overweight or Obese Adult Subjects

NCT07166081 ·Status: RECRUITING ·Phase: PHASE1

A First Human Dose Trial Investigating Safety, Tolerability and Pharmacokinetics for Single Doses and Multiple Doses of NNC0165-1562 in Overweight to Obese But Otherwise Healthy Subjects

NCT02568306 ·Status: COMPLETED ·Phase: PHASE1

Phase Ib Clinical Study on the Efficacy and Safety of MDR-001 in Patients Who Are Obesity or Overweight

NCT07110766 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1

Study of NGM395 in Adult Participants

NCT04187339 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety of ZT006 in Overweight and Obese Participants

NCT07230132 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2